Review



tricaprin  (Larodan)


Bioz Verified Symbol Larodan is a verified supplier
Bioz Manufacturer Symbol Larodan manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Larodan tricaprin
    Tricaprin, supplied by Larodan, used in various techniques. Bioz Stars score: 92/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tricaprin/us12329731-189-14-19?v=Larodan
    Average 92 stars, based on 4 article reviews
    tricaprin - by Bioz Stars, 2026-07
    92/100 stars

    Images



    Similar Products

    tricaprin  (Larodan)
    92
    Larodan tricaprin
    Tricaprin, supplied by Larodan, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tricaprin/us12329731-189-14-19?v=Larodan
    Average 92 stars, based on 1 article reviews
    tricaprin - by Bioz Stars, 2026-07
    92/100 stars
    		  Buy from Supplier
    120 tricaprin  (Tokyo Chemical Industry)
    86
    Tokyo Chemical Industry 120 tricaprin
    120 Tricaprin, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tricaprin/pm42264231-48-0-5?v=Tokyo+Chemical+Industry
    Average 86 stars, based on 1 article reviews
    120 tricaprin - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    tricaprin  (Tokyo Chemical Industry)
    86
    Tokyo Chemical Industry tricaprin
    Effect of cryoprotectant concentration on the formulations of <t>tricaprin</t> at 14 wt% with varied in pegylated/unpegylated lipid surfactant blends after freeze–thaw on Day 2 after formulation. (A) Photos of each formulation before freeze thaw and after freeze thaw with different concentrations of cryoprotectant (no cryoprotectant, 1, 5 and 10% w/sucrose). (B) The z-average diameter and PDI of each of the samples as measured by DLS at ∼0.58 mg mL −1 excluding sucrose.
    Tricaprin, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tricaprin/pmc12781925-229-0-4?v=Tokyo+Chemical+Industry
    Average 86 stars, based on 1 article reviews
    tricaprin - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    tricaprin  (Fluka Chemical)
    90
    Fluka Chemical tricaprin
    Effect of cryoprotectant concentration on the formulations of <t>tricaprin</t> at 14 wt% with varied in pegylated/unpegylated lipid surfactant blends after freeze–thaw on Day 2 after formulation. (A) Photos of each formulation before freeze thaw and after freeze thaw with different concentrations of cryoprotectant (no cryoprotectant, 1, 5 and 10% w/sucrose). (B) The z-average diameter and PDI of each of the samples as measured by DLS at ∼0.58 mg mL −1 excluding sucrose.
    Tricaprin, supplied by Fluka Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tricaprin/us12269932-22-1-2?v=Fluka+Chemical
    Average 90 stars, based on 1 article reviews
    tricaprin - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    tricaprin  (Millipore)
    90
    Millipore tricaprin
    Effect of cryoprotectant concentration on the formulations of <t>tricaprin</t> at 14 wt% with varied in pegylated/unpegylated lipid surfactant blends after freeze–thaw on Day 2 after formulation. (A) Photos of each formulation before freeze thaw and after freeze thaw with different concentrations of cryoprotectant (no cryoprotectant, 1, 5 and 10% w/sucrose). (B) The z-average diameter and PDI of each of the samples as measured by DLS at ∼0.58 mg mL −1 excluding sucrose.
    Tricaprin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tricaprin/10__1016_slash_j__renene__2024__121183-63-45-46?v=Millipore
    Average 90 stars, based on 1 article reviews
    tricaprin - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Effect of cryoprotectant concentration on the formulations of tricaprin at 14 wt% with varied in pegylated/unpegylated lipid surfactant blends after freeze–thaw on Day 2 after formulation. (A) Photos of each formulation before freeze thaw and after freeze thaw with different concentrations of cryoprotectant (no cryoprotectant, 1, 5 and 10% w/sucrose). (B) The z-average diameter and PDI of each of the samples as measured by DLS at ∼0.58 mg mL −1 excluding sucrose.

    Journal: Nanoscale Advances

    Article Title: Bis-prodrug cryopreserved lipid nanoparticles with enzymatically triggered release

    doi: 10.1039/d5na00675a

    Figure Lengend Snippet: Effect of cryoprotectant concentration on the formulations of tricaprin at 14 wt% with varied in pegylated/unpegylated lipid surfactant blends after freeze–thaw on Day 2 after formulation. (A) Photos of each formulation before freeze thaw and after freeze thaw with different concentrations of cryoprotectant (no cryoprotectant, 1, 5 and 10% w/sucrose). (B) The z-average diameter and PDI of each of the samples as measured by DLS at ∼0.58 mg mL −1 excluding sucrose.

    Article Snippet: Tricaprin was purchased from Tokyo chemical industry and used as received.

    Techniques: Concentration Assay, Formulation

    Effect of cryoprotectant concentration and surfactant composition on appearance of the formulations after freeze–drying and after redispersion samples were freeze-dried on Day 2 after formulation. (A) Photos of each formulation's cake once freeze-dried with different concentrations of cryoprotectant (sucrose) as well as surfactant composition. (B) Photos of each of the same formulation before and after lyophilization. (C) Z-average diameter, and PDI obtained by DLS. All formulations contained tricaprin at 14 wt% with varied in pegylated/unpegylated lipid surfactant blends on a mass ratio. Measurements made at a fixed position of 4.65 mm in the DLS at ∼0.58 mg mL −1 excluding sucrose.

    Journal: Nanoscale Advances

    Article Title: Bis-prodrug cryopreserved lipid nanoparticles with enzymatically triggered release

    doi: 10.1039/d5na00675a

    Figure Lengend Snippet: Effect of cryoprotectant concentration and surfactant composition on appearance of the formulations after freeze–drying and after redispersion samples were freeze-dried on Day 2 after formulation. (A) Photos of each formulation's cake once freeze-dried with different concentrations of cryoprotectant (sucrose) as well as surfactant composition. (B) Photos of each of the same formulation before and after lyophilization. (C) Z-average diameter, and PDI obtained by DLS. All formulations contained tricaprin at 14 wt% with varied in pegylated/unpegylated lipid surfactant blends on a mass ratio. Measurements made at a fixed position of 4.65 mm in the DLS at ∼0.58 mg mL −1 excluding sucrose.

    Article Snippet: Tricaprin was purchased from Tokyo chemical industry and used as received.

    Techniques: Concentration Assay, Formulation, Lyophilization

    Characterisation of the formulations of tricaprin at 33 wt% varied in pegylated/unpegylated lipid surfactant blends on a mass ratio. (A) Z-average particle diameter and PDI of the different surfactant formulations, prefreezing, after freeze thaw, and after freeze drying and redispersion as measured by DLS with 10% w/v of sucrose cryoprotectant. (B) Z-average particle diameter and PDI as measured by DLS and formulations made of dodecyl prodrug/tricaprin blends at an overall 33 wt% varied in pegylated/unpegylated lipid surfactant blends on a mass ratio. (C and D) CryoSEM images of the formulation at 33 wt% with a core composition of 50/50, 3 : 1, while also in the presence of 10% w/v sucrose. Before freeze drying (C) and redispersed after freeze drying (D).

    Journal: Nanoscale Advances

    Article Title: Bis-prodrug cryopreserved lipid nanoparticles with enzymatically triggered release

    doi: 10.1039/d5na00675a

    Figure Lengend Snippet: Characterisation of the formulations of tricaprin at 33 wt% varied in pegylated/unpegylated lipid surfactant blends on a mass ratio. (A) Z-average particle diameter and PDI of the different surfactant formulations, prefreezing, after freeze thaw, and after freeze drying and redispersion as measured by DLS with 10% w/v of sucrose cryoprotectant. (B) Z-average particle diameter and PDI as measured by DLS and formulations made of dodecyl prodrug/tricaprin blends at an overall 33 wt% varied in pegylated/unpegylated lipid surfactant blends on a mass ratio. (C and D) CryoSEM images of the formulation at 33 wt% with a core composition of 50/50, 3 : 1, while also in the presence of 10% w/v sucrose. Before freeze drying (C) and redispersed after freeze drying (D).

    Article Snippet: Tricaprin was purchased from Tokyo chemical industry and used as received.

    Techniques: Formulation